Desmoid Tumors (1 companies)

Companies with an active program in Desmoid Tumors.

Ticker	Company	Therapeutic areas	Programs	Lead stage	Mkt cap	Programs
IMNM	Immunome	Oncology Rare	1	NDA Submitted	$2.13B	9